Skip to content
10-Q

Quarterly Report

Aegerion Pharmaceuticals, Inc.

0001558370-16-007783

← back to feed
Filed
Aug 9, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 3, 2016 29.51M sh
Capex Q2 2016 · Jun 30, 2016 $563K
Capex Q2 2016 · Jun 30, 2015 $619K
Short Term Debt Q2 2016 · Jun 30, 2016 $2.84M
Cash And Equivalents Q2 2016 · Jun 30, 2016 $46.06M
Cash And Equivalents Q2 2016 · Dec 31, 2015 $64.5M
Cash And Equivalents Q2 2016 · Jun 30, 2015 $82.56M
Cash And Equivalents Q2 2016 · Dec 31, 2014 $375.94M
Stockholders Equity Q2 2016 · Jun 30, 2016 $11.12M
Stockholders Equity Q2 2016 · Dec 31, 2015 $115.55M
Current Liabilities Q2 2016 · Jun 30, 2016 $122.35M
Current Liabilities Q2 2016 · Dec 31, 2015 $86.89M
Total Liabilities Q2 2016 · Jun 30, 2016 $364.76M
Total Liabilities Q2 2016 · Dec 31, 2015 $318.65M
Current Assets Q2 2016 · Jun 30, 2016 $138.36M
Current Assets Q2 2016 · Dec 31, 2015 $175.94M
Total Assets Q2 2016 · Jun 30, 2016 $375.88M
Total Assets Q2 2016 · Dec 31, 2015 $434.2M
Sga Expense Q2 2016 · Jun 30, 2016 $40.43M
Sga Expense Q2 2016 · Jun 30, 2016 $80.12M
Sga Expense Q2 2016 · Jun 30, 2015 $42.67M
Sga Expense Q2 2016 · Jun 30, 2015 $89.6M
Rd Expense Q2 2016 · Jun 30, 2016 $10.68M
Rd Expense Q2 2016 · Jun 30, 2016 $20.56M
Rd Expense Q2 2016 · Jun 30, 2015 $12.47M
Rd Expense Q2 2016 · Jun 30, 2015 $22.27M
Net Income Q2 2016 · Jun 30, 2016 −$46.81M
Net Income Q2 2016 · Jun 30, 2016 −$112.36M
Net Income Q2 2016 · Jun 30, 2015 −$11.15M
Net Income Q2 2016 · Jun 30, 2015 −$26.98M
Operating Income Q2 2016 · Jun 30, 2016 −$39.35M
Operating Income Q2 2016 · Jun 30, 2016 −$98.19M
Operating Income Q2 2016 · Jun 30, 2015 −$4.94M
Operating Income Q2 2016 · Jun 30, 2015 −$14.12M
Cost Of Revenue Q2 2016 · Jun 30, 2016 $23.06M
Cost Of Revenue Q2 2016 · Jun 30, 2016 $38.03M
Cost Of Revenue Q2 2016 · Jun 30, 2015 $14M
Cost Of Revenue Q2 2016 · Jun 30, 2015 $25.84M